++
+++
Essentials of Diagnosis
++
May present with one or more of the following:
Dyspnea
Pleuritic chest pain
Hemoptysis
Syncope
Tachypnea, tachycardia, hypoxia (alone or in combination) may be present
Risk stratification with clinical scores, cardiac biomarkers, and right ventricular imaging is key for management
+++
General Considerations
++
Venous thromboembolism (VTE), often referred to as pulmonary embolism (PE), is often clinically silent until it presents with significant morbidity or mortality
Pulmonary thromboemboli most often originate in deep veins of the lower extremities
Risk factors for PE include the Virchow triad, which comprises
Venous stasis (eg, due to immobility, hyperviscosity, increased central venous pressures)
Injury to the vessel wall (eg, due to prior episodes of thrombosis, orthopedic surgery, trauma)
Hypercoagulability (eg, due to medications, disease, inherited gene defects or acquired thrombophilias)
Pulmonary thromboembolism (PE) develops in 50–60% of patients with proximal lower extremity deep venous thrombosis (DVT); 50% of these events are asymptomatic
Hypoxemia results from vascular obstruction leading to dead space ventilation, right-to-left shunting, and decreased cardiac output
Other types of pulmonary emboli
Fat embolism
Air embolism
Amniotic fluid embolism
Septic embolism (eg, endocarditis)
Tumor embolism (eg, renal cell carcinoma)
Foreign body embolism (eg, talc in injection drug use)
Parasite egg embolism (schistosomiasis)
++
++
++
+++
Differential Diagnosis
++
Myocardial infarction
Pneumonia
Pericarditis
Heart failure
Pleuritis (pleurisy)
Pneumothorax
Pericardial tamponade
++